Burford Brothers Inc. purchased a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 32,243 shares of the real estate investment trust's stock, valued at approximately $1,182,000.
Several other institutional investors have also bought and sold shares of OHI. AQR Capital Management LLC increased its holdings in shares of Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock worth $108,989,000 after buying an additional 2,322,878 shares during the last quarter. Vanguard Group Inc. increased its stake in Omega Healthcare Investors by 3.9% during the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock worth $1,506,250,000 after acquiring an additional 1,492,904 shares during the last quarter. Invesco Ltd. raised its position in Omega Healthcare Investors by 122.3% during the first quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust's stock valued at $92,023,000 after purchasing an additional 1,329,324 shares during the period. Nuveen LLC bought a new stake in shares of Omega Healthcare Investors in the 1st quarter valued at approximately $42,513,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Omega Healthcare Investors by 556.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust's stock worth $39,143,000 after purchasing an additional 871,472 shares during the period. Institutional investors own 65.25% of the company's stock.
Omega Healthcare Investors Trading Up 1.8%
Shares of OHI opened at $41.07 on Friday. The firm has a market capitalization of $12.12 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 1.92 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. Omega Healthcare Investors, Inc. has a 1-year low of $35.04 and a 1-year high of $44.42. The company has a 50-day moving average of $41.58 and a 200 day moving average of $38.89.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same period in the prior year, the firm earned $0.71 EPS. The company's revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.
Omega Healthcare Investors Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.5%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.
Analysts Set New Price Targets
Several research firms recently weighed in on OHI. Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Cantor Fitzgerald assumed coverage on shares of Omega Healthcare Investors in a report on Wednesday, October 1st. They issued an "overweight" rating and a $50.00 target price for the company. Mizuho upped their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a report on Thursday, September 11th. Wells Fargo & Company increased their price objective on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. Finally, Truist Financial boosted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research report on Wednesday, September 3rd. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $44.38.
View Our Latest Report on Omega Healthcare Investors
Insider Activity
In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.50% of the company's stock.
Omega Healthcare Investors Company Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.